Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities

Diagnostic Cytopathology

Volumn 21, Issue 1, 1999, Pages 39-42

  Collins, Brian T ^a,b   Lowe, Val J ^a   Dunphy, Frank R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytology; FDG PET; Needle biopsy; Neoplasia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LIVER BIOPSY; LIVER METASTASIS; LIVER SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY;

BIOPSY, NEEDLE; FLUORODEOXYGLUCOSE F18; HUMANS; LEIOMYOSARCOMA; LIVER; LIVER NEOPLASMS; LYMPHOMA, NON-HODGKIN; MELANOMA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032977515     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199907)21:1<39::AID-DC11>3.0.CO;2-L     Document Type: Article

References (8)

1. Duhaylongsod FG, Lowe VJ, Patz EF Jr. Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995;110:130-140.
2. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
3. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-382.
4. Jadvar H, Segall GM. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 1997;38:1382-1383.
5. Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, Ferlin G, Pedrazzoli S. Neuroendocrine tumor imaging - can f-18-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior. World J Surg 1998;22:588-592.
6. Lowe VJ, Fletcher JW, Gobar L, Lawson M. Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998;16:1075-1084.
7. Changlai SP, Kao CH, Chieng PU. 18f-2-fluoro-2-deoxy-d-glucose positron emission tomography of head and neck in patients with nasopharyngeal carcinomas. Oncol Rep 1997;4:1331-1334.
8. Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, Baddeley H, Tierney P. Maisey M. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997;22:209-214.